News

FDA is warning about an increased risk of death and blood clots in the lungs in patients with rheumatoid arthritis taking a specific dosage of this drug.

Managed Healthcare Executive asked key opinion leaders “What is the one book healthcare executives should read this year?” Here are their selections.

A new report from Humana shows the benefits of value-based care for patients and providers.

Here’s five things to take away from Anthem’s launch of PBM IngenioRx.

Many patients who were prescribed fentanyl should not have received the drug, a new study said.

FDA is requiring the addition of a Black Box Warning to a gout drug that has an increased risk of death.

HCCI Releases 2017 Health Care Cost and Utilization Report. Here are the revealing findings.

A new study suggests that the FDA and manufacturers did not act when evidence emerged that potentially lethal fentanyl products were being inappropriately prescribed to patients.

Loneliness leads to more healthcare utilization and decreases the likelihood of a positive health outcome post-hospital discharge-but it is underappreciated and rarely well addressed by the healthcare community.

Read the supplement here.

FDA approved first interoperable insulin pump, as well as the only FDA-approved drug for patients with a neglected tropical disease.

We asked healthcare industry leaders to tell us about how their organizations are using technology-from big data to remote monitoring devices. Here’s what they said.

A southern California health system asked its in-hospital physician groups to contract with its insurance carriers. Here’s what happened.

Why you need to move from a fixed mindset to a growth mindset-learning from your failures and changing how you see your abilities.

An analysis by Mergermarket, an Acuris company, reveals the top U.S. cities for healthcare M&A.

Managed care organizations need to look at how they can better manage their provider data-or risk getting left behind in a pile of spreadsheets.

In his recent State of the Union address, President Trump promised to continue lowering drug prices and fund research for HIV/AIDS and childhood cancer. Here are the ways experts say he will implement those pledges.

Healthcare growth opportunities for 2019 should pivot around the three big themes: digital transformation, value-based care, and patient-centricity.

FDA warns companies illegally selling drugs and dietary supplements claiming to cure Alzheimer’s and other conditions.

A group of community providers around Charlotte, North Carolina, joined to create a special workgroup to ensure that veterans have the best possible support to lead healthy lives.

Healthcare industry leaders share the biggest issues they foresee for their organizations. What can we expect in 2019?

Health plans have limited budgets for technology innovations. Here are eight questions to ask to help you determine what new technologies will offer the most value.

Workplace conflict is unavoidable, so it’s vital that healthcare executives learn how to resolve and manage diverse perspectives to create a high-performing organization. Here are 11 expert tips on how to manage conflict.

From diabetes to pneumonia, how hospitals are eliminating waste and creating healthier patients.

Jim Barlow of Geneos Therapeutics explains the role of value networks and strategies to increase cell therapy access.

Aetna and Apple partner on a new wellness app that combines activity-driven incentives and rewards with personalized health recommendations. Experts share their reactions.

FDA approved the first generic of a popular inhaler to treat asthma and chronic obstructive pulmonary disease

Are you getting the most out of your smartphone? From more knowledge to great efficiencies, these apps can get you more hours in a day.

Experts discuss what these trends entail, what’s giving them momentum, and how executives can get on board.